HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult Participants
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gavin Churchyard, MBBCh, FCP, MMed, PhD
Aurum Health Research Limited
Study Chair - Michael Keefer, MD
University of Rochester
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Projeto Praca Onze/hesfa Crs
Rio de Janeiro, Brazil
- Sao Paulo Hvtu - Crt Dst/aids Crs
São Paulo, Brazil
- Les Centres Gheskio Crs
Port-au-Prince, Haiti
- Epidemiology Research & Training Unit Jamaica Moh Crs
Kingston, Jamaica
- Soweto Hvtn Crs
Johannesburg, Gauteng, South Africa
- Emavundleni Desmond Tutu Hiv Centre Crs
Cape Town, South Africa
- Caprisa Aurum Crs
Klerksdorp, South Africa
- Alabama Vaccine Crs
Birmingham, Alabama, United States
- Project Brave Hiv Vaccine Crs
Baltimore, Maryland, United States
- Brigham and Women'S Hosp. Crs
Boston, Massachusetts, United States
- Miriam Hospital'S Hvtu
Providence, Rhode Island, United States
- Vanderbilt Vaccine Crs
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2005
- Primary completion
- 29 Feb 2008
- Completion
- 31 Jan 2010
- Last update posted
- 15 Oct 2021
- Registered enrollment
- 480
- Registry id
- NCT00125970
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.